Home/Filings/4/0001209191-19-060775
4//SEC Filing

Walter Blane 4

Accession 0001209191-19-060775

CIK 0001610853other

Filed

Dec 15, 7:00 PM ET

Accepted

Dec 16, 7:57 PM ET

Size

13.0 KB

Accession

0001209191-19-060775

Insider Transaction Report

Form 4
Period: 2019-12-07
Walter Blane
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-12-07+20,00020,000 total
    Exercise: $5.35Exp: 2026-07-13Class A Common Stock (20,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2019-12-0710,0000 total
    Exercise: $4.48Exp: 2020-12-31Class A Common Stock (10,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2019-12-0720,0000 total
    Exercise: $5.35Exp: 2020-07-13Class A Common Stock (20,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2019-12-07+10,00010,000 total
    Exercise: $4.48Exp: 2025-12-31Class A Common Stock (10,000 underlying)
Footnotes (3)
  • [F1]These two reported transactions involved an amendment of an outstanding option originally granted on December 31, 2015 resulting in the deemed cancellation of the December 31, 2015 option and the grant of a replacement option with the same terms other than the expiration date.
  • [F2]Immediately exercisable.
  • [F3]These two reported transactions involved an amendment of an outstanding option originally granted on July 13, 2016 resulting in the deemed cancellation of the July 13, 2016 option and the grant of a replacement option with the same terms other than the expiration date.

Issuer

HELIUS MEDICAL TECHNOLOGIES, INC.

CIK 0001610853

Entity typeother

Related Parties

1
  • filerCIK 0001340555

Filing Metadata

Form type
4
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 7:57 PM ET
Size
13.0 KB